Summary:
- Cullen Capital Management, LLC sold over 6.5 million shares of Kenvue, valued at $149.46 million.
- The fund reduced its Kenvue stake to 0.6% of assets under management, with top holdings in other companies.
- Kenvue Inc. operates globally in the consumer health sector, offering a range of essential health and personal care products.
Article:
Cullen Capital Management, LLC recently made a significant move in the market by disclosing the sale of 6,565,339 shares of Kenvue (KVUE) during the second quarter of 2025. This transaction, valued at approximately $149.46 million, reflects a strategic decision by the fund to adjust its investment portfolio. The reduction in Kenvue shares now positions the company’s stake at 0.6% of assets under management, showcasing a shift in focus towards other top holdings in the market.
Following the sale, Cullen Capital Management, LLC retained 2,484,940 shares of Kenvue with a value of $52.01 million as of Q2 2025. This move aligns with the fund’s investment strategy and portfolio diversification efforts. Additionally, the fund’s top holdings after the filing included companies like JPMorgan Chase, Cisco Systems, Bank of America, Novartis, and Duke Energy, each representing a significant portion of assets under management.
Kenvue Inc. operates as a global consumer health company, offering a diverse range of consumer health products across three segments: Self Care, Skin Health and Beauty, and Essential Health. With a strong presence in the over-the-counter and personal care markets, Kenvue’s strategic focus on essential health and self-care positions it competitively within the consumer defensive sector. The company’s revenue, net income, dividend yield, and current stock price reflect its stability and potential for growth in the market.
In conclusion, Cullen Capital Management’s decision to reduce its stake in Kenvue highlights the dynamic nature of investment management and the importance of strategic portfolio adjustments. While Kenvue’s stock performance has faced challenges in the past year, the company’s profitability and dividend yield remain attractive to investors. Monitoring Kenvue’s future earnings stability and dividend sustainability will be crucial for investors and institutions following Cullen’s lead in the market.
